PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 5, 2025Deleted Journal0 citations

Method Development, Validation and Simultaneous Estimation of Bilastine and Montelukast using RP-HPLC

View Full Paper
DSD SwehtaSCSuresh ChKAK Amol

Key Points

  • The method achieved a precision of below 2.0% RSD for quantifying bilastine and montelukast, ensuring reliable results.
  • Bilastine and montelukast had retention times of 2.462 and 2.061 minutes respectively in the RP-HPLC method.
  • Chromatography utilized a Zorbax C18 column and a mobile phase of methanol and phosphate buffer, enhancing separation efficiency.
  • This method facilitates quality control in pharmaceutical formulations, supporting accurate dosage measurements.

Abstract

A rapid and precise reverse phase high performance liquid chromatographic method has been developed for the validated of Montelukast and Bilastine, in its pure form as well as in tablet dosage form. Chromatography was carried out on a Zorbax C18 (4.6x150mm, 5µm) column using a mixture of Methanol: Phosphate Buffer pH 3.9 (55:45v/v) as the mobile phase at a flow rate of 1.0ml/min, the detection was carried out at 255nm. The retention time of the Montelukast and Bilastine was 2.061, 2.462±0.02min respectively. The method produce linear responses in the concentration range of 1-5µg/ml of Montelukast and 100-500µg/ml of Bilastine. The method precision for the determination of assay was below 2.0%RSD. The method is useful in the quality control of bulk and pharmaceutical formulations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Swehta et al. (2025) studied this question.

synapsesocial.com/papers/68af59d7ad7bf08b1eade5ddhttps://doi.org/10.30904/j.ajcpr.2025.4837
Ask AI
Helpful
Bookmark
Share
View Full Paper